These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9007852)

  • 21. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
    Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S
    Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
    Mizisin AP; Calcutt NA; Tomlinson DR; Gallagher A; Fernyhough P
    J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway.
    Love A; Cotter MA; Cameron NE
    Brain Res; 1995 Dec; 703(1-2):105-10. PubMed ID: 8719622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of simvastatin and alpha-tocopherol on disturbed nerve conduction in obese Sprague Dawley rats.
    Jabeen A; Khan UA; Ayub M; Hameed MA
    J Ayub Med Coll Abbottabad; 2011; 23(3):18-22. PubMed ID: 23272426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA
    Eur J Clin Invest; 1995 Jan; 25(1):19-24. PubMed ID: 7705382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latency of neuroactivity and optimum period of treatment with evening primrose oil in diabetic rats.
    Julu PO
    J Lipid Mediat Cell Signal; 1996 Mar; 13(2):99-113. PubMed ID: 8925199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms.
    Kennedy JM; Zochodne DW
    Brain; 2000 Oct; 123 ( Pt 10)():2118-29. PubMed ID: 11004128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.
    Lockett MJ; Tomlinson DR
    Br J Pharmacol; 1992 Feb; 105(2):355-60. PubMed ID: 1313726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids.
    Karasu C; Dewhurst M; Stevens EJ; Tomlinson DR
    Diabetologia; 1995 Feb; 38(2):129-34. PubMed ID: 7713308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an extracellular metal chelator on neurovascular function in diabetic rats.
    Cameron NE; Cotter MA
    Diabetologia; 2001 May; 44(5):621-8. PubMed ID: 11380081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats.
    Cotter MA; Cameron NE
    Life Sci; 2003 Aug; 73(14):1813-24. PubMed ID: 12888120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats.
    van Dam PS; Bravenboer B; van Asbeck BS; Marx JJ; Gispen WH
    Eur J Pharmacol; 1999 Jul; 376(3):217-22. PubMed ID: 10448879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR; Mayer JH
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl-L-carnitine effects on nerve conduction and glycemic regulation in experimental diabetes.
    Soneru IL; Khan T; Orfalian Z; Abraira C
    Endocr Res; 1997; 23(1-2):27-36. PubMed ID: 9187536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
    Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.